OR WAIT null SECS
June 21, 2022
Orbit Discovery has been awarded the Innovate UK Grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery.
June 17, 2022
FDA has issued an Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines in children as young as six months old.
Batavia Biosciences is expanding its headquarters and R&D capabilities in its Netherlands facility.
Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.
SCHOTT is planning to triple its ready-to-use vial production capacity in the United States to meet increasing demand for storing injectable drugs.
Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.
Measure tackles infant formula, cosmetics, diagnostics plus drug development and access.
Humanigen and PCI Pharma Servicesare partnering up for the commercialization of lenzilumab.
MHRA has been accepted as a full member of three international work-sharing partnerships aimed at making sure medicines and medical devices are regulated safely and efficiently across the world.
NICE has published its final draft guidance recommending the use of Vazkepa (icosapent ethyl) in adults to reduce heart attacks and strokes.